🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Liquid biopsy to advance precision oncology for patients with breast cancer ➡️ highlights from SABCS 2024 📢 Check our editorial just published in the The Journal of Liquid Biopsy here: sciencedirect.com/science/articl… Letizia Pontolillo Mohamed A Gouda Konstantinos Venetis Carolina Reduzzi International Society of Liquid Biopsy

📢 International Society of Liquid Biopsy conducting global survey 🌎 on #attitudes, #practices & #barriers of #liquidbiopsies for practicing #oncologists. Aim: Find #strategies to improve #implementation. Help shape this by completing survey here 👉: docs.google.com/forms/d/e/1FAI… Ana Ortega Franco

📌Liquid Biopsy Highlights from SABCS 2024 - International Society of Liquid Biopsy oncodaily.com/url/232619 Eleonora Nicolò Carolina Reduzzi Konstantinos Venetis Mohamed A Gouda Letizia Pontolillo #Cancer #LiquidBiopsy #SABCS24 #MedX #MedNews #Health #Medicine #OncoDaily #Oncology

Researchers from the Cristofanilli CTC Laboratory were involved with a number of abstracts presented at #SABCS24 on the role of circulating tumor cells (CTCs) in a variety of types of #BreastCancer, including invasive lobular carcinoma (ILC), invasive ductal carcinoma (IDC), and HER2+ #cancer.

Dr. Massimo Cristofanilli and collaborators from across Weill Cornell Medicine, Cristofanilli CTC Laboratory and Italy shared #research at #SABCS24 on how tumor cell-derived exomes impact the landscape of inflammatory #BreastCancer.

.Cristofanilli CTC Laboratory team members gave insights into their #research involvement on the use of circulating tumor DNA (#ctDNA) testing for both advanced and early-stage #BreastCancer at #SABCS24

Survey Participation Request on Behalf of International Society of Liquid Biopsy & OncoAlert Oncologist Attitudes and Practices on Liquid Biopsy 👉 buff.ly/4gn5GON This survey aims to evaluate oncologists' attitudes, practices, and barriers to the use of liquid biopsy in clinical care.

You’ve heard me say that #LiquidBiopsies are here to stay. A lot of the talk is about circulating tumor DNA🧬ctDNA. Circulating Tumor Cells➖CTCs🟣🟠🔴 are another less talked about lens🔍. Intact cells➕Membrane🔬. 📕 📖 👇🏽here’s our work as a chapter/article. OncoAlert 🧵1/

Happy to have contributed to this work showing the effect of bone metastasis on #HER2 expression and secondary metastatic dissemination in HR+/HER2- metastatic #BreastCancer Out now on Cancer Discovery! Cristofanilli CTC Laboratory Weill Cornell Medicine Igor Bado doi.org/10.1158/2159-8…

Survey Participation Request on Behalf of International Society of Liquid Biopsy & OncoAlert Oncologist Attitudes and Practices on Liquid Biopsy 👉 buff.ly/4kgngY6 This survey aims to evaluate oncologists' attitudes, practices, and barriers to the use of liquid biopsy in clinical care. Your

Our new #CTC review is published today via Elsevier. Congrats to the authors youbin zhang David Scholten, Wenan Qiang Leonidas Platanias, MD William Gradishar, MD Shana Kelley Lurie Cancer Center Northwestern Feinberg School of Medicine and Chan Zuckerberg Biohub Network Thanks to Carolina Reduzzi and Lorenzo Gerratana authors.elsevier.com/a/1kfqy_i3fF9a…

pubmed.ncbi.nlm.nih.gov/39998904/ Our meta-analysis aggregates data from more the 30 studies comprising 3000+ patients, showing that ctDNA decrease and clearance are strongly associated with PFS and OS in lung cancer. Results hold true for targeted treatments and immunotherapy! @iaslc

Now you can find the link to complete our International Society of Liquid Biopsy survey in the OncoAlert newsletter! 📨 It only takes 5 min to help us understand how LB 🩸 is reshaping clinical practice worldwide! bit.ly/43JzN03 Carolina Reduzzi Christian Rolfo Umberto Malapelle Gil Morgan, MD

The International Society of Liquid Biopsy (International Society of Liquid Biopsy) is conducting a global survey on the use of Liquid Biopsy in clinical practice. Your input will help shape strategies to improve its implementation and effectiveness in cancer care worldwide. 🌍 Carolina Reduzzi

2025 ISLB Annual Congress, will take place in Orlando, Florida, November 1-3, 2025. This is an extraordinary gathering of scientists, clinicians, industry leaders, and innovators, all united by a shared passion for advancing liquid biopsy 2025.islb.info

The Liquid Biopsy Platform is launching a new seminar series within the HemOnc Seminar Talk - Carolina Reduzzi (Carolina Reduzzi) Weill Cornell Medicine oncodaily.com/blog/carolina-… #OncoDaily #Oncology #Cancer #Health #Medicine #MedTwitter #MedEd #MedOnc #MedNews

🩸👀See how WCM Englander Institute for Precision Medicine is using #LiquidBiopsy to improve #PrecisionMedicine w/ Hashem Alshurafa Guardant Health eipm.weill.cornell.edu/research/resea…

Super excited to share our latest review in the Journal of Liquid Biopsy on the huge impact of LB in oncology! 🩸🔬 LB is reshaping cancer care💥 👉pubmed.ncbi.nlm.nih.gov/40255897/ International Society of Liquid Biopsy Carolina Reduzzi The James RolfoLab Weill Cornell Medicine Umberto Malapelle Christian Rolfo